
==== Front
BMC Infect Dis
BMC Infect Dis
BMC Infectious Diseases
1471-2334
BioMed Central London

9844
10.1186/s12879-024-09844-6
Case Report
Acute necrotizing encephalopathy in adult patients with influenza: a case report and review of the literature
http://orcid.org/0009-0006-9563-0540
Chen Hsi 1
http://orcid.org/0000-0002-8175-4933
Lan Shih-Chun 2
http://orcid.org/0009-0006-8138-3876
Tseng Yu-Lung 1
http://orcid.org/0000-0001-6840-8537
Chang Yung-Yee 13
http://orcid.org/0000-0002-4075-6983
Lu Yan-Ting 1
http://orcid.org/0000-0001-7361-8475
Lan Min-Yu myl@ksts.seed.net.tw

134
1 https://ror.org/00k194y12 grid.413804.a Department of Neurology, Kaohsiung Chang Gung Memorial Hospital, 123 Ta-Pei Road, NiaoSong, Kaohsiung 833 Taiwan
2 https://ror.org/05bqach95 grid.19188.39 0000 0004 0546 0241 School of Medicine, National Taiwan University College of Medicine, Taipei, Taiwan
3 https://ror.org/02verss31 grid.413801.f 0000 0001 0711 0593 Center for Parkinson’s Disease, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan
4 grid.413804.a Center for Mitochondrial Research and Medicine, Kaohsiung Chang Gung Memorial Hospital and, Chang Gung University College of Medicine, Kaohsiung, Taiwan
9 9 2024
9 9 2024
2024
24 93119 6 2024
30 8 2024
© The Author(s) 2024
2024
https://creativecommons.org/licenses/by-nc-nd/4.0/ Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
The neurological complications of influenza affect mainly the pediatric Asian population. In the category of influenza-associated encephalopathy, acute necrotizing encephalopathy (ANE) is a rapidly progressive and fulminant brain disorder associated with significant neurological sequelae and mortality. To date, only a few adult cases of influenza-associated ANE have been reported. We describe a 44-year-old woman who presented with rapid progression of consciousness impairment and recurrent generalized convulsions. Influenza was diagnosed three days prior to presentation, and infection with influenza A (H3N2) pdm09 was subsequently confirmed. A diagnosis of ANE was made based on the presence of characteristic brain MRI findings, the exclusion of central nervous system infection, and an elevated serum interleukin-6 level. Pulse steroid therapy followed by tocilizumab was initiated, which led to clinical stabilization and improvement. Genetic testing revealed that the patient carried heterozygous human leukocyte antigen DQB1 03:03 and DRB1 09:01 genotypes. An analysis of the adult cases of influenza-associated ANE in the literature and the present case revealed a wide range of ages (22–71 years), a short interval (median 3 days) between the clinical onset of influenza and ANE, and a high overall mortality rate (32%). The thalamus was the most frequent (91%) location of the lesions. Our report highlights the importance of identifying this devastating but treatable neurological complication of influenza in adults, especially those of Asian descent. As a cytokine storm is the most accepted pathogenic mechanism for ANE, cytokine-directed therapies may be promising treatments for which further investigation is warranted.

Keywords

Acute necrotizing encephalopathy
Influenza
Cytokine
Adult
issue-copyright-statement© BioMed Central Ltd., part of Springer Nature 2024
==== Body
pmcBackground

Influenza is a highly contagious infectious disease that causes a substantial burden on health services. Seasonal epidemics of influenza lead to approximately one billion cases worldwide, including 3 to 5 million cases of severe illness associated with a death rate of up to 10% [1]. In Taiwan, the Center of Disease Control noted 3.5 to 9.5 influenza cases with severe complications per 100,000 people annually during the pre-COVID-19 epidemic era [2]. Moreover, influenza may be associated with diverse complications along the neuroaxis. The most common neurological complications are seizure and influenza-associated encephalopathy. Less common or rare conditions include meningitis, central nervous system demyelination, Reye syndrome, stroke, Guillain–Barré syndrome and myopathy [3, 4]. Influenza-associated neurological complications affect mainly pediatric patients, occurring in up to 7.6 to 16.9% of children hospitalized with influenza [3, 5–7]. Moreover, Asian race has been identified as a risk factor for the development of influenza-associated neurological complications [3].

In the category of influenza-associated encephalopathy, acute necrotizing encephalopathy (ANE) is a rare brain disorder characterized by multiple symmetric brain lesions, alterations in mental status with rapidly progressive neurological deterioration, and a high rate of significant neurological sequelae or mortality [8]. ANE usually develops following infection with various viruses, including influenza A and B, SARS-CoV-2, enterovirus, human herpesvirus 6 (HHV-6) and dengue virus, and rarely Mycoplasma pneumoniae [8]. However, there is little evidence of direct brain invasion by infectious pathogens. In some cases, ANE can occur spontaneously, recurs, or is associated with a family history, suggesting an underlying genetic predisposition [9]. In line with this, mutations in RANBP2 have been found to be linked to the development of a specific type of ANE that is named ANE1 [9].

Since it was first described in Japanese children in 1995 [10], ANE has been found to predominantly affect the Asian pediatric population, especially those under 5 years of age [11]. In contrast, only a limited number of adult cases of influenza-associated ANE have been reported to date. Here, we report the case of an adult patient with ANE and antecedent infection with influenza A virus who subsequently received steroid and anticytokine treatment and survived. We also report our findings from a review of the literature on adult cases of influenza-associated ANE.

Case presentation

A 44-year-old Taiwanese female with a history of thyroid goiter had headache, fever, sore throat, cough and rhinorrhea in August 2023. She was diagnosed with influenza A infection through a rapid throat swab test on the third day of symptom presentation and was treated with inhaled zanamivir. The next day, she was sent to the emergency service because of sudden alterations in consciousness and recurrent tonic‒clonic seizure episodes. Her Glasgow Coma Scale (GCS) score was E1V1M4, temperature was 37.2 °C, blood pressure was 112/52 mmHg, and heart rate was 95/min. Her blood leukocyte count was 7100/μL (neutrophil percentage = 87.7%), C-reactive protein level was 7.89 mg/L (normal < 5), aspartate aminotransferase level was 41 U/L (normal < 34), alanine aminotransferase level was 24 U/L (normal < 36), ammonia level was 72 μg/dL (normal < 96), and creatinine level was 0.61 mg/dL. Brain CT showed multiple subcortical hypodense lesions in the bilateral cerebral hemispheres. Cerebrospinal fluid (CSF) analysis revealed one monocyte/μL, 1080 erythrocytes/μL, an elevated protein level (77 mg/dL), and normal glucose (84 mg/dL) and lactate (18.3 mg/dL) levels. She subsequently required endotracheal intubation for mechanical ventilation due to respiratory failure. Lorazepam and levetiracetam (for status epilepticus), peramivir (for severe complicated influenza) and ceftriaxone (empiric antibiotic for suspected adult bacterial meningitis) were given.

She was admitted to the neurology intensive care unit on Day 2 of the neurological episode. Electroencephalography demonstrated generalized continuous theta activity. Her neurological condition improved only slightly (GCS E3VeM4), although her seizure activity subsided after treatment. Brain MRI revealed extensive T2 and FLAIR-hyperintense lesions in the white matter of the bilateral cerebral hemisphere, corpus callosum, thalamus, and midbrain and the right middle cerebellar peduncle (Fig. 1A-E). Some of the lesions contained areas of restricted diffusion (Fig. 1F). Proton magnetic resonance spectroscopy revealed increased intensity of the lactate peaks in the white matter lesions (Fig. 1G). Autoantibodies from the autoimmune encephalitis panel were negative. For detecting pathogens, the patient’s CSF was examined for bacterial culture, virus isolation and DNA of herpes simplex virus (HSV) and varicella zoster virus (VZV), and tested with a FilmArray Meningitis/Encephalitis Panel (bioMérieux, France) for detecting genomes of cytomegalovirus, enterovirus, HSV-1, HSV-2, VZV, human herpes virus 6, human parechovirus, E. coli K1, Haemophilus influenzae, Listeria monocytogenes, Neisseria meningitides, Streptococcus agalactiae, Streptococcus pneumonia, and Cryptococcus neoformans/gattii. Serological tests for Japanese encephalitis virus and dengue viruses were negative. bacterial culture, virus isolation, serological tests and PCR for genome for various infectious pathogens in CSF were all negative. Acute disseminated encephalomyelitis (ADEM) was initially considered, and steroid therapy (methylprednisolone 1 g/day for five days, followed by oral prednisolone 1 g/kg body weight/day) was initiated on Day 5. Repeated brain MRI on Day 9 revealed similar findings. On Day 11, a blood test revealed an increase in the interleukin-6 (IL-6) level (46.7 pg/ml, normal < 7) despite the concurrent use of steroids. On the basis of these findings, combined with the prodromal viral infection, the brain MRI findings and the exclusion of infectious encephalitis, ANE related to influenza A was diagnosed. A dose of tocilizumab 400 mg (2 mg/kg body weight) was thus administered intravenously, and oral prednisolone treatment was continued. She soon became more awake and was able to open her eyes spontaneously two days later. The endotracheal tube and mechanical ventilation were removed on Day 17. Urinary tract infection by Klebsiella aerogenes developed on Day 18, which resolved with a course of treatment with cefperazone/sulbactam. However, the residual neurological deficits were severe. She presented with akinetic mutism (GCS E4V1M4) with general spasticity, rigidity and hyperreflexia and was wheelchair-ridden when discharged one month later. She needed one-person assistance to stand, had a modified Rankin scale score of 4, and had the same neurological examination findings three months after discharge.Fig. 1 A-E Brain MRI demonstrated diffuse and generally symmetric T2 and FLAIR-hyperintense lesions in the white matter of the bilateral cerebral hemisphere, corpus callosum, thalamus and midbrain (A, B, D, E, FLAIR; C, T2 weighted image). Small areas of restricted diffusion were present (F, diffuse weighted image). 1H-magnetic resonance spectroscopy revealed increased intensity of lactate peaks in the cerebral white matter lesion (G, arrow)

Infection with the influenza A(H3N2)pdm09 strain was subsequently confirmed by RT‒PCR. To investigate genetic predisposition for ANE, sequence-based genotyping for HLA and CPT2 were performed. It revealed that the patient carried heterozygous HLA-DQB1 03:03 and HLA-DRB1 09:01 alleles and was homozygous for p.lIe368 and p.Met647 in CPT2, all of these four variants having been associated with increased risk for ANE [12, 13].

Discussion

Review of the literature on adult cases of influenza-associated ANE

We searched in PubMed and Google Scholar with the terms “acute necrotizing encephalopathy”, “influenza” and “adult” without limitation of language from 1995 (the year ANE first described). After eliminating duplicate cases and including the present case, we identified a total of 22 adult (≥ 18 years of age) patients (11 males, 11 females) with influenza-associated ANE, with one patient who experienced an ANE episode during childhood (Table 1) [14–33]. The ages ranged from 22 to 71 (median 47) years. The influenza type was known in 20 patients, including influenza A in 15 patients and influenza B in 5 patients. Among the 9 patients who received influenza A virus typing, the H1N1 strain was identified in 7, and the H3N2 strain was identified in the other 2. Table 1 Clinical characteristics, treatment and outcome of adult influenza-associated ANE cases

Case No	1	2	3	4	5	6	
Age	27	40	46	40	53	46	
Gender	F	F	M	F	F	F	
Medical history	None	None	None	NA	Human immunodeficiency virus infection	None	
Influenza (strain)	A (H1N1)	A (H1N1)	A (H1N1)	B	A (H1N1)	B	
Onset (days)a	NA	6	2	2	7	3	
Neurologic symptoms	Conscious impairment	 + 	 + 	 + 	-	-	-	
Altered mentality or behaviors	-	-	 + 	-	 + 	 + 	
Convulsive seizures	 + 	-	-	 + 	-	-	
Others	Incontinence, headache, vomiting	-	Weakness	-	Right hemiplegia	Weakness	
Blood test	CRP (mg/L)	252.9	158	-	122	-	-	
WBC count (/μL)	11200	17400	-	9400	12960	-	
AST/ALT (U/L)	60/-	-/-	-/-	87/88	-/-	-/-	
CSF profile	Protein (mg/dL)	128	Normal	78	268	29	617	
Cells (/mm3)	WBC: 10	None	None	WBC: 1.7	None	WBC: 9	
Brain lesions	Thalamus	 + 	 + 	 + 	 + 	-	 + 	
Cerebral hemisphere	-	 + 	-	 + 	 + 	-	
Brainstem	 + 	 + 	-	 + 	-	-	
Cerebellum	 + 	-	-	-	 + 	-	
Basal ganglion	-	-	 + 	-	-	-	
Corpus callosum	-	-	-	-	-	-	
Others	-	-	-	Hippocampus	-	-	
Immuno-therapy	Corticosteroids	 + 	-	 + 	 + 	 + 	 + 	
IVIg	-	 + 	-	-	-	 + 	
Others	-	-	-	-	-	-	
Outcome	Complete recovery	Rehabilitation	Complete recovery	Complete recovery	Motor dysfunction	Complete recovery	
Reference	[14]	[15]	[16]	[17]	[18]	[19]	
Case No	7	8	9	10	11	
Age	22	29	48	52	27	
Gender	M	M	M	M	F	
Medical history	Acute necrotizing encephalopathy	Diabetes mellitus	Diabetes mellitus	Renal transplantation for end-stage renal disease, use of mycophenolate and prednisolone	Diabetes mellitus, cerebral infarction	
Influenza (strain)	A	B	A	B	A (H1N1)	
Onset (days)a	NA	7	2	4	NA	
Neurologic symptoms	Conscious impairment	 + 	-	 + 	-	 + 	
Altered mentality or behaviors	-	 + 	 + 	 + 	 + 	
Convulsive seizures	-	-	 + 	 + 	-	
Others	-	-	-	-	Quadriparesis	
Blood test	CRP (mg/L)	-	-	-	12.8	-	
WBC count (/μL)	-	-	-	2180	-	
AST/ALT (U/L)	-/66	-/-	-/-	-/-	-/-	
CSF profile	Protein (mg/dL)	69	71	88.6	-	78	
Cells (/mm3)	Normal	WBC: 8

RBC: 5406

	WBC: 5	-	WBC: 7	
Brain lesions	Thalamus	 + 	 + 	 + 	 + 	 + 	
Cerebral hemisphere	 + 	 + 	 + 	-	 + 	
Brainstem	-	 + 	 + 	-	 + 	
Cerebellum	-	 + 	-	-	 + 	
Basal ganglion	-	 + 	 + 	-	-	
Corpus callosum	-	 + 	-	-	-	
Others	-	Hippocampus	Hippocampus, insula	-	-	
Immuno-therapy	Corticosteroids	-	 + 	 + 	 + 	 + 	
IVIg	-	 + 	-	 + 	 + 	
Others	-	-	-	-	-	
Outcome	Complete recovery	Died	Died	Died	Died	
Reference	[20]	[21]	[22]	[23]	[24]	
Case No	12	13	14	15	16	17	
Age	27	70	49	57	58	55	
Gender	M	F	F	F	M	M	
Medical history	Asthma, obesity	Retinal detachment	Diabetes mellitus, hepatitis B, hypertension, hyperlipidemia	Smoldering multiple myeloma, allergic rhinitis	Depression, hyperlipidemia	NA	
Influenza (strain)	A (H3N2)	A	B	A	NA	A (H1N1)	
Onset (days)a	1	0	3	2	3	0	
Neurologic symptoms	Conscious impairment	 + 	 + 	-	-	 + 	 + 	
Altered mentality or behaviors	-	-	 + 	 + 	 + 	-	
Convulsive seizures	 + 	 + 	-	-	-	-	
Others	-	Incontinence	-	Nonfluent expressive aphasia	-	-	
Blood test	CRP (mg/L)	-	7.5	5.8	-	-	153.3	
WBC count (/μL)	-	8100	3000	-	4700	10,420	
AST/ALT (U/L)	-/-	421/198	30/26	-/-	-/-	197/123	
CSF profile	Protein (mg/dL)	80	30	53	443	-	-	
Cells (/mm3)	WBC: 352	None	WBC: 1	WBC: 4, RBC: 11	-	-	
Brain lesions	Thalamus	 + 	 + 	 + 	 + 	 + 	-	
Cerebral hemisphere	 + 	 + 	-	 + 	 + 	-	
Brainstem	 + 	-	-	-	-	-	
Cerebellum	-	-	-	-	-	 + 	
Basal ganglion	-	-	-	-	-	 + 	
Corpus callosum	-	-	-	-	 + 	-	
Others	-	-	-	Insula	Insula	-	
Immuno-therapy	Corticosteroids	 + 	 + 	 + 	 + 	 + 	 + 	
IVIg	-	 + 	 + 	 + 	 + 	 + 	
Others	-	-	-	-	-	-	
Outcome	Rehabilitation	Rehabilitation	Rehabilitation	Aphasia, memory loss	Motor dysfunction	Complete recovery	
Reference	[25]	[26]	[26]	[27]	[28]	[29]	
Case No	18	19	20	21	22		
Age	70	59	71	40	44		
Gender	F	M	M	M	F		
Medical history	NA	NA	Diabetes mellitus, hypertension, benign prostate hyperplasia	None	Thyroid goiter		
Influenza (strain)	A	NA	A	A (H1N1)	A (H3N2)		
Onset (days)a	2	9	NA	3	3		
Neurologic symptoms	Conscious impairment	 + 	 + 	 + 	 + 	 + 		
	Altered mentality or behaviors	-	 + 	-	-	-		
	Convulsive seizures	-	-	-	 + 	 + 		
	Others	-	-	-	-	-		
Blood test	CRP (mg/L)	53.7	-	36.6	37.4	7.89		
	WBC count (/μL)	8500	-	14,100	-	7100		
	AST/ALT (U/L)	1305/894	-/-	2159/1197	167/118	41/24		
CSF profile	Protein (mg/dL)	-	152	-	72	77		
	Cells (/mm3)	-	WBC: 12	-	None	WBC: 1, RBC: 1080		
Brain lesions	Thalamus	 + 	 + 	 + 	 + 	 + 		
	Cerebral hemisphere	 + 	-	-	-	 + 		
	Brainstem	-	 + 	 + 	 + 	 + 		
	Cerebellum	-	-	 + 	 + 	 + 		
	Basal ganglion	-	-	-	-	-		
	Corpus callosum	-	-	-	-	 + 		
	Others	-	-	-	-	-		
Immuno-therapy	Corticosteroids	 + 	 + 	-	-	 + 		
	IVIg	-	-	-	-	-		
	Others	-	-	-	-	Tocilizumab		
Outcome	Died	Rehabilitation	Died	Died	Motor dysfunction		
Reference	[30]	[31]	[32]	[33]	Present case		
ALT alanine transaminase, ANE acute necrotizing encephalopathy, AST aspartate transaminase, CRP C-reactive protein, CSF cerebrospinal fluid, F female, IVIg intravenous immunoglobulin, M male, NA not available, RBC red blood cell, WBC white blood cell

aafter onset of influenza symptoms

The median interval between the onset of ANE and that of prodromal influenza was 3 days (ranging from 0 to 9 days, data available in 18 patients). The leading clinical manifestations were conscious impairment (68%), altered mentality or behaviors (50%) and convulsive seizures (36%). The most common neuroimaging abnormality was acute inflammation of the thalamus (91%), which was usually bilaterally affected, followed by the cerebral hemisphere (59%), brainstem (50%), cerebellum (36%), basal ganglion (18%) and corpus callosum (14%). Regarding CSF studies (performed in 17 patients), an increase in protein levels (> 45 mg/dl) was the most common abnormality (14 patients, 82%), while leukocyte pleocytosis (> 5/mm3) was found in only five (29%) patients. For immunotherapy, 9 patients received combined corticosteroids and intravenous immunoglobulin (IVIg) treatment, 9 received corticosteroids alone, and 1 received IVIg only. Our patient is the only one who received tocilizumab treatment. Seven patients died during acute stage of the disease, with a mortality rate 32%. The survival rate was 74% for patients receiving corticosteroids, IVIg or both and 33% for those not receiving immunotherapy, suggesting a statistically nonsignificant trend toward increased survival associated with any immunotherapy (odds ratio 5.6, 95% CI 0.41–76; p = 0.163). It is noteworthy, however, that the sample size was small, and the timing, type and duration of immunotherapy were highly variable among these patients. Compared with pediatric cases of ANE related to influenza or other pathogens, there were no obvious differences in the intervals between the onset of influenza and ANE, clinical presentations, brain images, CSF profiles or mortality rate for these adult cases of influenza-associated ANE.

Clinical manifestations of ANE

Despite the diversity of infection pathogens, the clinical, radiological and laboratory presentations of parainfectious ANE are relatively stereotypic. Clinically, three stages in the clinical course could be identified in most ANE patients [34]. During the prodromal stage, the patients presented systemic manifestations of acute viral infections, most frequently respiratory tract manifestations, as well as generalized symptoms such as fever, headache, myalgia and malaise, but still had normal consciousness. Brain imaging findings were usually normal at this stage. The acute encephalopathy stage followed suddenly a few days after prodromal onset. It was characterized by rapidly progressive neurological dysfunction with mental and conscious deterioration, which was often combined with seizures and focal neurological deficits. The typical brain imaging findings during this stage were multifocal and generally symmetric inflammatory lesions of the cerebral cortex, white matter, deep gray matter, cerebellum and brainstem, with bilateral thalamic involvement being the most common and distinctive presentation [35, 36]. Occasionally, petechial hemorrhage occurred in the lesions. Acute extraneural organ injury, such as hepatic, hematological and pulmonary dysfunction, occurred in some patients [37]. The mortality rate could reach 25–40% [8, 38, 39]. While some patients with catastrophic encephalopathy who survived recovered gradually in the following several weeks, most of them had persistent and significant neurological sequelae.

Diagnosis of ANE

The diagnostic criteria for ANE was proposed by Muzuguchi in 1997 [40]. Focusing on a neurological complication following viral infection and with exclusion of several clinical mimics in mind, this criteria encompasses the characteristic clinical presentation (rapid conscious alternation, convulsion), brain imaging features (symmetric multifocal lesions with bilateral thalamic lesions), CSF study findings (increase of protein level without leukocyte pleocytosis) and systemic involvement (increase of serum aminotransferase levels with elevation of ammonia). It is still widely applied to date in diagnosis of spontaneous or infection-provoked ANE.

The differential diagnosis for ANE includes practically all of the post-infectious central nervous system complications, with ADEM, Reye syndrome and infectious encephalitis as the leading conditions to consider. ADEM and ANE shared a lot of clinical similarities, such as rapid development of conscious disturbance, altered mentality, seizure and multiple brain lesions. While ANE occurs during the early febrile period of viral infection, ADEM typically develops up to several (mean 12.5) days after the initial symptoms and signs of infection subsides [41]. Different from normal cell counts in CSF in most cases of ANE [42], ADEM patients usually show neutrophil pleocytosis in CSF analysis. Regarding neuroimaging findings, the multiple brain lesions are generally symmetric in distribution in ANE and the bilateral thalamic involvement is highly specific. In contrast, the bilateral brain lesions are asymmetric and the bilateral thalamic lesion is present only in 30—50% of ADEM patients [43]. Reye syndrome also has similar clinical manifestations with ANE. However, the most common laboratory finding for Reye syndrome is hyperammonemia occurring 1 to 2 days after onset, sometimes combined with hypoglycemia and coagulation dysfunction. These findings however are absent in ANE patients [40]. Besides, imaging and pathology studies in Reye syndrome shows only diffuse brain edema, in contrast that multifocal lesions in neuroimaging are essential for diagnosing ANE. Finally, ANE can be differentiated from infectious meningoencephalitis through specific antibody testing, microbial culture or isolation, or direct detection of the pathogen genome in CSF.

Pathogenesis of ANE

Although the pathogenesis of ANE remains unclear, the uncontrolled production of proinflammatory cytokines by the innate immune system (“cytokine storm”) in response to viral infection is the most commonly proposed mechanism [8, 44]. The cytokines involved in ANE may include various interleukins, interferons and chemokines, with IL-6 and tumor necrosis factor-α being the most prominent [8, 44]. In in vivo and in vitro studies, the administration of IL-6 and tumor necrosis factor-α to cerebral vessels led to vasodilation, endothelial tight junction perturbation and subsequent blood‒brain barrier (BBB) breakdown [45–47]. In line with this, brain biopsy and postmortem pathologic examinations in ANE patients have shown minimal lymphocytic or neutrophilic infiltrations or demyelination, despite marked brain parenchyma abnormalities such as hemorrhagic or coagulation necrosis and edema and axonal damage [23, 24, 48–50], and CSF pleocytosis is usually absent [42]. In addition to disrupting BBB integrity, excessive cytokines also cause excitotoxic neuronal damage, immune cell overactivation and secondary organ damage. Microglial priming, a condition in which microglia multiply and become activated, may also underlie ANE. Priming increases the sensitivity of microglia to a secondary inflammatory stimulus (e.g., peripheral cytokine release), which can induce an exaggerated immunological response. This mechanism has been shown to contribute to the neurological complications associated with nonneurotropic influenza strains, such as H1N1 [51] and H3N2 [52]. Clinically, a higher serum level of IL-6 is correlated with the development of brainstem dysfunction, which has been associated with an increased risk of mortality in ANE patients [53, 54].

Host genetic factors of ANE

Genetic background may contribute to the predilection of ANE in East Asian populations. The HLA DQB1 03:03 and DRB1 09:01 genotypes and the thermolabile CPT2 variants, which have the highest frequencies in the eastern ethnicities, have been associated with ANE [12, 13]. Our patient carried two HLA alleles and two homozygous CPT2 risk variants for ANE. HLA genes govern antigen presentation and are crucial components of the human immune system. Carnitine palmitoyl transferase II, the protein encoded by CPT2, is one of the mitochondrial enzymes essential for long-chain fatty acid oxidation. Mitochondrial dysfunction and energy deficiency may underlie BBB disruption and cerebral edema in ANE [55]. On the other hand, the relationship between ANE1 (the ANE caused by RANBP2 mutations) penetrance and environmental triggers [9] and a case report of a Caucasian infant who resided in East Asia for the first several months of life and developed HHV-6-associated ANE three months after returning to a western country [56] imply the role of environmental factors in the predisposition to ANE occurrence. More studies are needed to elucidate the complexity of interactions between infectious pathogens and genetic or environmental factors in ANE development.

Treatment of ANE

Although there has been no definitive guideline for management of ANE to date, most recommended treatments involve immunotherapeutic regimens which are given early and in combinations. A retrospective case-series study showed that administration of corticosteroids, either methylprednisolone or dexamethasone, within 24 h after onset was associated with better prognosis [57]. The common immunomodulatory treatments combined with steroid include IVIg and plasmapheresis. Furthermore, regarding the potentially pivotal role of cytokines in ANE development, anticytokine therapy is considered a rational treatment for ANE. Tocilizumab, a monoclonal antibody blocking the IL-6 receptor, has been shown to significantly lower IL-6 levels and has become an emerging therapy for ANE. Case reports and a small uncontrolled study findings have suggested that tocilizumab may have synergistic effects with corticosteroid and may be effective for severe ANE when administered early in the disease course [58–61]. However, whether tocilizumab reduces mortality or possibility of severe neurological sequelae is still unclear.

Conclusions

In the face of the growing prevalence of re-emerging and emerging infectious diseases in recent years, the occurrence of neurological complications related to viral infections, including ANE, is expected to increase. For instance, with the pandemic of COVID-19, ANE related to SARS-CoV-2 has been increasingly recognized in recent years. SARS-CoV2-associated ANE is similar to influenza-associated ANE in presenting symptoms, onset time related to prodromal infection, typical locations of brain lesions, CSF and serum cytokine profiles, and disease outcome [62]. Remarkably, adult patients may account for a higher proportion in SARS-CoV2-associated ANE, up to 80% in a case series [62]. Our report highlights the importance of identifying this devastating but treatable neurological complication of viral infections in adults, especially in East Asian populations. In addition, cytokine-inhibiting monoclonal antibodies may be promising treatments for ANE, for which further investigation is warranted.

Abbreviations

ADEM Acute disseminated encephalomyelitis

ANE Acute necrotizing encephalopathy

BBB Blood‒brain barrier

CSF Cerebrospinal fluid

GCS Glasgow Coma Scale

HHV-6 Human herpesvirus 6

HLA Human leukocyte antigen

HSV Herpes simplex virus

IL-6 Interleukin 6

IVIg Intravenous immunoglobulin

VZV Varicella zoster virus

Acknowledgements

Not applicable.

Authors’ contributions

MYL, YLT and YYC: study conceptualization and design. HC, SCL, YLT and YTL: data collection. SCL: literature review. SCL and MYL: genetic testing and data analysis. HC: writing of the first draft. MYL: manuscript review and critique. All authors reviewed the manuscript and approved the submitted version.

Funding

None.

Availability of Data and Materials

The datasets generated and/or analyzed during the current study are available in the figshare repository, https://figshare.com/articles/figure/An_adult_case_of_acute_necrotizing_encephalopathy/25992166.

Declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

Written informed consent was obtained from the patient for the publication of this case report and any accompanying images.

Competing interests

The authors declare no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
==== Refs
References

1. World Health Organization website. https://www.who.int/news-room/fact-sheets/detail/influenza-(seasonal). Accessed 15 Apr 2024.
2. Taiwan Center for Disease Control website. https://www.cdc.gov.tw/Category/MPage/6YQ32GG9EOdXNTjPqUDT1A. Accessed 17 Apr 2024.
3. Antoon JW Hall M Herndon A Johnson DP Brown CM Browning WL Prevalence, risk factors, and outcomes of influenza-associated neurologic complications in children J Pediatr 2021 239 32 38.e5 10.1016/j.jpeds.2021.06.075 34216629
Antoon JW, Hall M, Herndon A, Johnson DP, Brown CM, Browning WL, et al. Prevalence, risk factors, and outcomes of influenza-associated neurologic complications in children. J Pediatr. 2021;239:32-38.e5.34216629 10.1016/j.jpeds.2021.06.075
4. Tsai JP Baker AJ Influenza-associated neurological complications Neurocrit Care 2013 18 118 130 10.1007/s12028-012-9796-8 23138546
Tsai JP, Baker AJ. Influenza-associated neurological complications. Neurocrit Care. 2013;18:118–30.23138546 10.1007/s12028-012-9796-8
5. Choi GJ Park JY Choi JS Choi SR Kim D Lee JH Influenza-associated neurologic complications in hospitalized pediatric patients: a multicenter retrospective study in Republic of Korea Pediatr Infect Dis J 2021 40 e466 e471 10.1097/INF.0000000000003332 34609108
Choi GJ, Park JY, Choi JS, Choi SR, Kim D, Lee JH, et al. Influenza-associated neurologic complications in hospitalized pediatric patients: a multicenter retrospective study in Republic of Korea. Pediatr Infect Dis J. 2021;40:e466–71.34609108 10.1097/INF.0000000000003332
6. Frankl S Coffin SE Harrison JB Swami SK McGuire JL Influenza-associated neurologic complications in hospitalized children J Pediatr 2021 239 24 31.e1 10.1016/j.jpeds.2021.07.039 34293371
Frankl S, Coffin SE, Harrison JB, Swami SK, McGuire JL. Influenza-associated neurologic complications in hospitalized children. J Pediatr. 2021;239:24-31.e1.34293371 10.1016/j.jpeds.2021.07.039
7. Jantarabenjakul W Paprad T Paprad T Anugulruengkitt S Pancharoen C Puthanakit T Neurological complications associated with influenza in hospitalized children Influenza Other Respir Viruses 2023 17 e13075 10.1111/irv.13075 36514185
Jantarabenjakul W, Paprad T, Paprad T, Anugulruengkitt S, Pancharoen C, Puthanakit T, et al. Neurological complications associated with influenza in hospitalized children. Influenza Other Respir Viruses. 2023;17:e13075.36514185 10.1111/irv.13075
8. Shukla P Mandalla A Elrick MJ Venkatesan A Clinical manifestations and pathogenesis of acute necrotizing encephalopathy: the interface between systemic infection and neurologic injury Front Neurol 2022 12 628811 10.3389/fneur.2021.628811 35058867
Shukla P, Mandalla A, Elrick MJ, Venkatesan A. Clinical manifestations and pathogenesis of acute necrotizing encephalopathy: the interface between systemic infection and neurologic injury. Front Neurol. 2022;12:628811.35058867 10.3389/fneur.2021.628811
9. Neilson DE Adams MD Orr CM Schelling DK Eiben RM Kerr DS Infection-triggered familial or recurrent cases of acute necrotizing encephalopathy caused by mutations in a component of the nuclear pore, RANBP2 Am J Hum Genet 2009 84 44 51 10.1016/j.ajhg.2008.12.009 19118815
Neilson DE, Adams MD, Orr CM, Schelling DK, Eiben RM, Kerr DS, et al. Infection-triggered familial or recurrent cases of acute necrotizing encephalopathy caused by mutations in a component of the nuclear pore, RANBP2. Am J Hum Genet. 2009;84:44–51.19118815 10.1016/j.ajhg.2008.12.009
10. Mizuguchi M Abe J Mikkaichi K Noma S Yoshida K Yamanaka T Acute necrotising encephalopathy of childhood: a new syndrome presenting with multifocal, symmetric brain lesions J Neurol Neurosurg Psychiatry 1995 58 555 561 10.1136/jnnp.58.5.555 7745402
Mizuguchi M, Abe J, Mikkaichi K, Noma S, Yoshida K, Yamanaka T, et al. Acute necrotising encephalopathy of childhood: a new syndrome presenting with multifocal, symmetric brain lesions. J Neurol Neurosurg Psychiatry. 1995;58:555–61.7745402 10.1136/jnnp.58.5.555
11. Wang GF Li W Li K Acute encephalopathy and encephalitis caused by influenza virus infection Curr Opin Neurol 2010 23 305 311 10.1097/WCO.0b013e328338f6c9 20455276
Wang GF, Li W, Li K. Acute encephalopathy and encephalitis caused by influenza virus infection. Curr Opin Neurol. 2010;23:305–11.20455276 10.1097/WCO.0b013e328338f6c9
12. Hoshino A Saitoh M Miyagawa T Kubota M Takanashi JI Miyamoto A Specific HLA genotypes confer susceptibility to acute necrotizing encephalopathy Genes Immun 2016 17 367 369 10.1038/gene.2016.32 27467284
Hoshino A, Saitoh M, Miyagawa T, Kubota M, Takanashi JI, Miyamoto A, et al. Specific HLA genotypes confer susceptibility to acute necrotizing encephalopathy. Genes Immun. 2016;17:367–9.27467284 10.1038/gene.2016.32
13. Shinohara M Saitoh M Takanashi J Yamanouchi H Kubota M Goto T Carnitine palmitoyl transferase II polymorphism is associated with multiple syndromes of acute encephalopathy with various infectious diseases Brain Dev 2011 33 512 517 10.1016/j.braindev.2010.09.002 20934285
Shinohara M, Saitoh M, Takanashi J, Yamanouchi H, Kubota M, Goto T, et al. Carnitine palmitoyl transferase II polymorphism is associated with multiple syndromes of acute encephalopathy with various infectious diseases. Brain Dev. 2011;33:512–7.20934285 10.1016/j.braindev.2010.09.002
14. Abdelrahman HS Safwat AM Alsagheir MM Acute necrotizing encephalopathy in an adult as a complication of H1N1 infection BJR Case Rep 2019 5 20190028 31938561
Abdelrahman HS, Safwat AM, Alsagheir MM. Acute necrotizing encephalopathy in an adult as a complication of H1N1 infection. BJR Case Rep. 2019;5:20190028.31938561
15. Alkhashan S Samir N Acute necrotizing encephalitis in an adult patient with novel influenza A (H1N1) infection Open Access J Neurol Neurosurg 2015 1 1 4
Alkhashan S, Samir N. Acute necrotizing encephalitis in an adult patient with novel influenza A (H1N1) infection. Open Access J Neurol Neurosurg. 2015;1:1–4.
16. Alsolami A Shiley K Successful treatment of influenza-associated acute necrotizing encephalitis in an adult using high-dose oseltamivir and methylprednisolone: case report and literature review Open Forum Infect Dis 2017 4 ofx145 10.1093/ofid/ofx145 28852683
Alsolami A, Shiley K. Successful treatment of influenza-associated acute necrotizing encephalitis in an adult using high-dose oseltamivir and methylprednisolone: case report and literature review. Open Forum Infect Dis. 2017;4:ofx145.28852683 10.1093/ofid/ofx145
17. Bloch C Suter B Fischmann A Gensicke H Rüegg S Weisser M Only a touch of the flu? the simultaneous manifestation of acute necrotizing encephalopathy in two consanguineous patients Open Forum Infect Dis 2015 2 ofv013 10.1093/ofid/ofv013 26110162
Bloch C, Suter B, Fischmann A, Gensicke H, Rüegg S, Weisser M. Only a touch of the flu? the simultaneous manifestation of acute necrotizing encephalopathy in two consanguineous patients. Open Forum Infect Dis. 2015;2:ofv013.26110162 10.1093/ofid/ofv013
18. Chen KC Gow CH Yang CJ Chang HT Successful high-dosage dexamethasone treatment of H1N1 influenza A pneumonia complicated with acute necrotizing encephalitis in an HIV-Infected adult Case Rep Clin Med 2015 4 245 249 10.4236/crcm.2015.47048
Chen KC, Gow CH, Yang CJ, Chang HT. Successful high-dosage dexamethasone treatment of H1N1 influenza A pneumonia complicated with acute necrotizing encephalitis in an HIV-Infected adult. Case Rep Clin Med. 2015;4:245–9.10.4236/crcm.2015.47048
19. Erdil E Vural E Koytak PK Tuncer EN Successful treatment of influenza B associated acute necrotizing encephalopathy in an adult using combination of high dose oseltamivir-IVIG-pulse methylprednisolone Acta Neurol Belg 2021 121 1863 1865 10.1007/s13760-020-01462-8 32772325
Erdil E, Vural E, Koytak PK, Tuncer EN. Successful treatment of influenza B associated acute necrotizing encephalopathy in an adult using combination of high dose oseltamivir-IVIG-pulse methylprednisolone. Acta Neurol Belg. 2021;121:1863–5.32772325 10.1007/s13760-020-01462-8
20. Fasano A Natoli GF Cianfoni A Ferraro D Loria G Bentivoglio AR Servidei S Acute necrotizing encephalopathy: a relapsing case in a European adult J Neurol Neurosurg Psychiatry 2008 79 227 228 10.1136/jnnp.2007.127670 17846107
Fasano A, Natoli GF, Cianfoni A, Ferraro D, Loria G, Bentivoglio AR, Servidei S. Acute necrotizing encephalopathy: a relapsing case in a European adult. J Neurol Neurosurg Psychiatry. 2008;79:227–8. 10.1136/jnnp.2007.127670.17846107 10.1136/jnnp.2007.127670
21. Hernandez R Ota R Medina Y Hernandez Y Julayanont P Wilms H Acute necrotizing encephalopathy Proc (Bayl Univ Med Cent) 2022 35 725 727 35991737
Hernandez R, Ota R, Medina Y, Hernandez Y, Julayanont P, Wilms H. Acute necrotizing encephalopathy. Proc (Bayl Univ Med Cent). 2022;35:725–7.35991737
22. Huijsmans RLN Braber A Fokke C Lo Ten Foe JR Kuindersma M Influenza-geassocieerde acute necroticserende encefalitis Ned Tijdschr Geneeskd 2023 167 D7537 38175574
Huijsmans RLN, Braber A, Fokke C, Lo Ten Foe JR, Kuindersma M. Influenza-geassocieerde acute necroticserende encefalitis. Ned Tijdschr Geneeskd. 2023;167:D7537 (Dutch).38175574
23. Ishii N Mochizuki H Moriguchi-Goto S Shintaku M Asada Y Taniguchi A Shiomi K Nakazato M An autopsy case of elderly-onset acute necrotizing encephalopathy secondary to influenza J Neurol Sci 2015 354 1–2 129 130 10.1016/j.jns.2015.04.051 25982501
Ishii N, Mochizuki H, Moriguchi-Goto S, Shintaku M, Asada Y, Taniguchi A, Shiomi K, Nakazato M. An autopsy case of elderly-onset acute necrotizing encephalopathy secondary to influenza. J Neurol Sci. 2015;354(1–2):129–30.25982501 10.1016/j.jns.2015.04.051
24. Lee YJ Smith DS Rao VA Siegel RD Kosek J Glaser CA Flint AC Fatal H1N1-related acute necrotizing encephalopathy in an adult Case Rep Crit Care 2011 2011 562516 562516 24826323
Lee YJ, Smith DS, Rao VA, Siegel RD, Kosek J, Glaser CA, Flint AC. Fatal H1N1-related acute necrotizing encephalopathy in an adult. Case Rep Crit Care. 2011;2011(562516).24826323
25. Iijima H Wakasugi K Ayabe M Shoji H Abe T A case of adult influenza A virus-associated encephalitis: magnetic resonance imaging findings J Neuroimaging 2002 12 273 275 12116748
Iijima H, Wakasugi K, Ayabe M, Shoji H, Abe T. A case of adult influenza A virus-associated encephalitis: magnetic resonance imaging findings. J Neuroimaging. 2002;12:273–5.12116748
26. Iizuka K Suzuki K Shiina T Nakamura T Funakoshi K Hirata K Two adult patients with acute necrotizing encephalopathy following influenza virus infection Rinsho Shinkeigaku 2020 60 157 61 10.5692/clinicalneurol.cn-001381 31956199
Iizuka K, Suzuki K, Shiina T, Nakamura T, Funakoshi K, Hirata K. Two adult patients with acute necrotizing encephalopathy following influenza virus infection. Rinsho Shinkeigaku. 2020;60:157–61. (Japanese).31956199 10.5692/clinicalneurol.cn-001381
27. McCray BA Forst D Jindal J Henderson GV Clinical reasoning: A 57-year-old woman who developed acute amnesia following fever and upper respiratory symptoms Neurology 2015 84 e102 e106 10.1212/WNL.0000000000001438 25847000
McCray BA, Forst D, Jindal J, Henderson GV. Clinical reasoning: A 57-year-old woman who developed acute amnesia following fever and upper respiratory symptoms. Neurology. 2015;84:e102–6.25847000 10.1212/WNL.0000000000001438
28. Meijer WJ Linn FH Wensing AM Leavis HL van Riel D GeurtsvanKessel CH Wattjes MP Murk JL Acute influenza virus-associated encephalitis and encephalopathy in adults: a challenging diagnosis JMM Case Rep 2016 3 e005076 10.1099/jmmcr.0.005076 28348797
Meijer WJ, Linn FH, Wensing AM, Leavis HL, van Riel D, GeurtsvanKessel CH, Wattjes MP, Murk JL. Acute influenza virus-associated encephalitis and encephalopathy in adults: a challenging diagnosis. JMM Case Rep. 2016;3:e005076.28348797 10.1099/jmmcr.0.005076
29. Ochi N Takahashi K Yamane H Takigawa N Acute necrotizing encephalopathy in an adult with influenza A infection Ther Clin Risk Manag 2018 14 753 756 10.2147/TCRM.S160111 29720877
Ochi N, Takahashi K, Yamane H, Takigawa N. Acute necrotizing encephalopathy in an adult with influenza A infection. Ther Clin Risk Manag. 2018;14:753–6.29720877 10.2147/TCRM.S160111
30. Odagiri A Yamaoka A Miyata K Bunya N Kasai T Takeyama Y Uemura S Mikami T Narimatsu E Elderly-onset acute necrotizing encephalopathy mimicking severe heat stroke: a case report and review of the literature Acute Med Surg 2019 6 316 320 10.1002/ams2.418 31304037
Odagiri A, Yamaoka A, Miyata K, Bunya N, Kasai T, Takeyama Y, Uemura S, Mikami T, Narimatsu E. Elderly-onset acute necrotizing encephalopathy mimicking severe heat stroke: a case report and review of the literature. Acute Med Surg. 2019;6:316–20.31304037 10.1002/ams2.418
31. Piradov MA Ryabinkina YV Luneva IE Polishchuk RV Chernobaeva LS Bormin AA Antipiat NA Ostryĭ nekroticheskiĭ éntsefalit, assotsiirovannyĭ s virusom grippa u vzroslykh Zh Nevrol Psikhiatr Im S S Korsakova 2019 119 100 105 10.17116/jnevro2019119121100 31994522
Piradov MA, Ryabinkina YV, Luneva IE, Polishchuk RV, Chernobaeva LS, Bormin AA, Antipiat NA. Ostryĭ nekroticheskiĭ éntsefalit, assotsiirovannyĭ s virusom grippa u vzroslykh. Zh Nevrol Psikhiatr Im S S Korsakova. 2019;119:100–5 (Russian).31994522 10.17116/jnevro2019119121100
32. Tsubota M Kato A Goshima T Imai K Yamagishi Y Matsushima A Sasano H Hattori T Rapidly progressive acute necrotizing encephalopathy associated with influenza A in an elderly adult Acute Med Surg 2020 7 e611 10.1002/ams2.611 33318805
Tsubota M, Kato A, Goshima T, Imai K, Yamagishi Y, Matsushima A, Sasano H, Hattori T. Rapidly progressive acute necrotizing encephalopathy associated with influenza A in an elderly adult. Acute Med Surg. 2020;7:e611.33318805 10.1002/ams2.611
33. Ventura E Summa A Ormitti F Picetti E Crisi G Influenza A H1N1 related acute necrotizing encephalopathy: radiological findings in adulthood Neuroradiol J 2012 25 397 401 10.1177/197140091202500401 24029031
Ventura E, Summa A, Ormitti F, Picetti E, Crisi G. Influenza A H1N1 related acute necrotizing encephalopathy: radiological findings in adulthood. Neuroradiol J. 2012;25:397–401.24029031 10.1177/197140091202500401
34. Levine JM Ahsan N Ho E Santoro JD Genetic acute necrotizing encephalopathy associated with RANBP2: clinical and therapeutic implications in pediatrics Mult Scler Relat Disord 2020 43 102194 10.1016/j.msard.2020.102194 32426208
Levine JM, Ahsan N, Ho E, Santoro JD. Genetic acute necrotizing encephalopathy associated with RANBP2: clinical and therapeutic implications in pediatrics. Mult Scler Relat Disord. 2020;43:102194.32426208 10.1016/j.msard.2020.102194
35. Vanjare HA Selvi BT Karuppusami R Manesh A Gunasekaran K Prabhakar AT Clinical and radiologic findings of acute necrotizing encephalopathy in young adults AJNR Am J Neuroradiol 2020 41 2250 2254 10.3174/ajnr.A6803 33122207
Vanjare HA, Selvi BT, Karuppusami R, Manesh A, Gunasekaran K, Prabhakar AT, et al. Clinical and radiologic findings of acute necrotizing encephalopathy in young adults. AJNR Am J Neuroradiol. 2020;41:2250–4.33122207 10.3174/ajnr.A6803
36. Wu L Peng H Jiang Y He L Jiang L Hu Y Clinical features and imaging manifestations of acute necrotizing encephalopathy in children Int J Dev Neurosci 2022 82 447 457 10.1002/jdn.10201 35688614
Wu L, Peng H, Jiang Y, He L, Jiang L, Hu Y. Clinical features and imaging manifestations of acute necrotizing encephalopathy in children. Int J Dev Neurosci. 2022;82:447–57.35688614 10.1002/jdn.10201
37. Lee YJ Hwang SK Kwon S Acute necrotizing encephalopathy in children: a long way to go J Korean Med Sci 2019 34 e143 10.3346/jkms.2019.34.e143 31099193
Lee YJ, Hwang SK, Kwon S. Acute necrotizing encephalopathy in children: a long way to go. J Korean Med Sci. 2019;34:e143.31099193 10.3346/jkms.2019.34.e143
38. Mizuguchi M Acute necrotizing encephalopathy Nihon Rinsho 2011 69 465 470 21400840
Mizuguchi M. Acute necrotizing encephalopathy. Nihon Rinsho. 2011;69:465–70.21400840
39. Lee CG Kim JH Lee M Lee J Clinical outcome of acute necrotizing encephalopathy in related to involving the brain stem of single institution in Korea Korean J Pediatr 2014 57 264 270 10.3345/kjp.2014.57.6.264 25076971
Lee CG, Kim JH, Lee M, Lee J. Clinical outcome of acute necrotizing encephalopathy in related to involving the brain stem of single institution in Korea. Korean J Pediatr. 2014;57:264–70.25076971 10.3345/kjp.2014.57.6.264
40. Mizuguchi M Acute necrotizing encephalopathy of childhood: a novel form of acute encephalopathy prevalent in Japan and Taiwan Brain Dev 1997 19 81 92 10.1016/S0387-7604(96)00063-0 9105653
Mizuguchi M. Acute necrotizing encephalopathy of childhood: a novel form of acute encephalopathy prevalent in Japan and Taiwan. Brain Dev. 1997;19:81–92.9105653 10.1016/S0387-7604(96)00063-0
41. Li K Li M Wen L Wang Q Ding X Wang J Clinical presentation and outcomes of acute disseminated encephalomyelitis in adults worldwide: systematic review and meta-analysis Front Immunol 2022 13 870867 10.3389/fimmu.2022.870867 35757742
Li K, Li M, Wen L, Wang Q, Ding X, Wang J. Clinical presentation and outcomes of acute disseminated encephalomyelitis in adults worldwide: systematic review and meta-analysis. Front Immunol. 2022;13:870867.35757742 10.3389/fimmu.2022.870867
42. Wu X Wu W Pan W Wu L Liu K Zhang HL Acute necrotizing encephalopathy: an under recognized clinicoradiologic disorder Mediators Inflamm 2015 2015 792578 10.1155/2015/792578 25873770
Wu X, Wu W, Pan W, Wu L, Liu K, Zhang HL. Acute necrotizing encephalopathy: an under recognized clinicoradiologic disorder. Mediators Inflamm. 2015;2015:792578.25873770 10.1155/2015/792578
43. Alper G. Acute necrotizing encephalopathy mimicking ADEM. In: Waubant E, Lotze TE, editors. Pediatric demyelinating diseases of the central nervous system and their mimics: a case-based clinical guide. Cham: Springer; 2017. p. 11–5.
44. Qin N Wang J Peng X Wang L Pathogenesis and management of acute necrotizing encephalopathy Expert Rev Neurother 2023 23 641 650 10.1080/14737175.2023.2224503 37309119
Qin N, Wang J, Peng X, Wang L. Pathogenesis and management of acute necrotizing encephalopathy. Expert Rev Neurother. 2023;23:641–50.37309119 10.1080/14737175.2023.2224503
45. de Vries HE Blom-Roosemalen MC van Oosten M de Boer AG van Berkel TJ Breimer DD The influence of cytokines on the integrity of the blood-brain barrier in vitro J Neuroimmunol 1996 64 37 43 10.1016/0165-5728(95)00148-4 8598388
de Vries HE, Blom-Roosemalen MC, van Oosten M, de Boer AG, van Berkel TJ, Breimer DD, et al. The influence of cytokines on the integrity of the blood-brain barrier in vitro. J Neuroimmunol. 1996;64:37–43.8598388 10.1016/0165-5728(95)00148-4
46. Tsao N Hsu HP Wu CM Liu CC Lei HY Tumour necrosis factor-alpha causes an increase in blood-brain barrier permeability during sepsis J Med Microbiol 2001 50 812 821 10.1099/0022-1317-50-9-812 11549183
Tsao N, Hsu HP, Wu CM, Liu CC, Lei HY. Tumour necrosis factor-alpha causes an increase in blood-brain barrier permeability during sepsis. J Med Microbiol. 2001;50:812–21.11549183 10.1099/0022-1317-50-9-812
47. Cheng Y Desse S Martinez A Worthen RJ Jope RS Beurel E TNFα disrupts blood brain barrier integrity to maintain prolonged depressive-like behavior in mice Brain Behav Immun 2018 69 556 567 10.1016/j.bbi.2018.02.003 29452218
Cheng Y, Desse S, Martinez A, Worthen RJ, Jope RS, Beurel E. TNFα disrupts blood brain barrier integrity to maintain prolonged depressive-like behavior in mice. Brain Behav Immun. 2018;69:556–67.29452218 10.1016/j.bbi.2018.02.003
48. Chen CI Mar S Brown S Song SK Benzinger TL Neuropathologic correlates for diffusion tensor imaging in postinfectious encephalopathy Pediatr Neurol 2011 44 389 393 10.1016/j.pediatrneurol.2010.12.007 21481751
Chen CI, Mar S, Brown S, Song SK, Benzinger TL. Neuropathologic correlates for diffusion tensor imaging in postinfectious encephalopathy. Pediatr Neurol. 2011;44:389–93.21481751 10.1016/j.pediatrneurol.2010.12.007
49. San Millan B Teijeira S Penin C Garcia JL Navarro C Acute necrotizing encephalopathy of childhood: report of a Spanish case Pediatr Neurol 2007 37 438 441 10.1016/j.pediatrneurol.2007.07.007 18021928
San Millan B, Teijeira S, Penin C, Garcia JL, Navarro C. Acute necrotizing encephalopathy of childhood: report of a Spanish case. Pediatr Neurol. 2007;37:438–41.18021928 10.1016/j.pediatrneurol.2007.07.007
50. Lyon JB Remigio C Milligan T Deline C Acute necrotizing encephalopathy in a child with H1N1 influenza infection Pediatr Radiol 2010 40 200 205 10.1007/s00247-009-1487-z 20020117
Lyon JB, Remigio C, Milligan T, Deline C. Acute necrotizing encephalopathy in a child with H1N1 influenza infection. Pediatr Radiol. 2010;40:200–5.20020117 10.1007/s00247-009-1487-z
51. Jurgens HA Amancherla K Johnson RW Influenza infection induces neuroinflammation, alters hippocampal neuron morphology, and impairs cognition in adult mice J Neurosci 2012 32 3958 3968 10.1523/JNEUROSCI.6389-11.2012 22442063
Jurgens HA, Amancherla K, Johnson RW. Influenza infection induces neuroinflammation, alters hippocampal neuron morphology, and impairs cognition in adult mice. J Neurosci. 2012;32:3958–68.22442063 10.1523/JNEUROSCI.6389-11.2012
52. Hosseini S Wilk E Michaelsen-Preusse K Gerhauser I Baumgärtner W Geffers R Long-term neuroinflammation induced by influenza A virus infection and the impact on hippocampal neuron morphology and function J Neurosci 2018 38 3060 3080 10.1523/JNEUROSCI.1740-17.2018 29487124
Hosseini S, Wilk E, Michaelsen-Preusse K, Gerhauser I, Baumgärtner W, Geffers R, et al. Long-term neuroinflammation induced by influenza A virus infection and the impact on hippocampal neuron morphology and function. J Neurosci. 2018;38:3060–80.29487124 10.1523/JNEUROSCI.1740-17.2018
53. Aiba H Mochizuki M Kimura M Hojo H Predictive value of serum interleukin-6 level in influenza virus-associated encephalopathy Neurology 2001 57 295 299 10.1212/WNL.57.2.295 11468315
Aiba H, Mochizuki M, Kimura M, Hojo H. Predictive value of serum interleukin-6 level in influenza virus-associated encephalopathy. Neurology. 2001;57:295–9.11468315 10.1212/WNL.57.2.295
54. Ichiyama T Isumi H Ozawa H Matsubara T Morishima T Furukawa S Cerebrospinal fluid and serum levels of cytokines and soluble tumor necrosis factor receptor in influenza virus-associated encephalopathy Scand J Infect Dis 2003 35 59 61 10.1080/0036554021000026986 12685886
Ichiyama T, Isumi H, Ozawa H, Matsubara T, Morishima T, Furukawa S. Cerebrospinal fluid and serum levels of cytokines and soluble tumor necrosis factor receptor in influenza virus-associated encephalopathy. Scand J Infect Dis. 2003;35:59–61.12685886 10.1080/0036554021000026986
55. Kubota M Chida J Hoshino H Ozawa H Koide A Kashii H Thermolabile CPT II variants and low blood ATP levels are closely related to severity of acute encephalopathy in Japanese children Brain Dev 2012 34 20 27 10.1016/j.braindev.2010.12.012 21277129
Kubota M, Chida J, Hoshino H, Ozawa H, Koide A, Kashii H, et al. Thermolabile CPT II variants and low blood ATP levels are closely related to severity of acute encephalopathy in Japanese children. Brain Dev. 2012;34:20–7.21277129 10.1016/j.braindev.2010.12.012
56. Kansagra SM Gallentine WB Cytokine storm of acute necrotizing encephalopathy Pediatr Neurol 2011 45 400 402 10.1016/j.pediatrneurol.2011.09.007 22115004
Kansagra SM, Gallentine WB. Cytokine storm of acute necrotizing encephalopathy. Pediatr Neurol. 2011;45:400–2.22115004 10.1016/j.pediatrneurol.2011.09.007
57. Okumura A Mizuguchi M Kidokoro H Tanaka M Abe S Hosoya M Aiba H Maegaki Y Yamamoto H Tanabe T Noda E Imataka G Kurahashi H Outcome of acute necrotizing encephalopathy in relation to treatment with corticosteroids and gammaglobulin Brain Dev 2009 31 221 227 10.1016/j.braindev.2008.03.005 18456443
Okumura A, Mizuguchi M, Kidokoro H, Tanaka M, Abe S, Hosoya M, Aiba H, Maegaki Y, Yamamoto H, Tanabe T, Noda E, Imataka G, Kurahashi H. Outcome of acute necrotizing encephalopathy in relation to treatment with corticosteroids and gammaglobulin. Brain Dev. 2009;31:221–7.18456443 10.1016/j.braindev.2008.03.005
58. Hosie PH Lim C Scott TRD Cardamone M Farrar MA Frith C Treatment of severe acute necrotizing encephalopathy of childhood with interleukin-6 receptor blockade in the first 24 h as add-on immunotherapy shows favorable long-term outcome at 2 years Brain Dev 2023 45 401 407 10.1016/j.braindev.2023.03.002 36967317
Hosie PH, Lim C, Scott TRD, Cardamone M, Farrar MA, Frith C, et al. Treatment of severe acute necrotizing encephalopathy of childhood with interleukin-6 receptor blockade in the first 24 h as add-on immunotherapy shows favorable long-term outcome at 2 years. Brain Dev. 2023;45:401–7.36967317 10.1016/j.braindev.2023.03.002
59. Azmi A Zainal Abidin AS Good outcome with respect to acute necrotizing encephalitis in children associated with post-infectious SARS-CoV-2 Cureus 2023 15 e43198 37692682
Azmi A, Zainal Abidin AS. Good outcome with respect to acute necrotizing encephalitis in children associated with post-infectious SARS-CoV-2. Cureus. 2023;15:e43198.37692682
60. Huang Y Zhou B Hong S Cai Y A case report and literature review on tocilizumab-cured acute necrotizing encephalopathy caused by influenza A virus Front Pediatr 2024 12 792578 10.3389/fped.2024.1351478
Huang Y, Zhou B, Hong S, Cai Y. A case report and literature review on tocilizumab-cured acute necrotizing encephalopathy caused by influenza A virus. Front Pediatr. 2024;12:792578.10.3389/fped.2024.1351478
61. Koh JC Murugasu A Krishnappa J Thomas T Favorable outcomes with early interleukin 6 receptor blockade in severe acute necrotizing encephalopathy of childhood Pediatr Neurol 2019 98 80 84 10.1016/j.pediatrneurol.2019.04.009 31201070
Koh JC, Murugasu A, Krishnappa J, Thomas T. Favorable outcomes with early interleukin 6 receptor blockade in severe acute necrotizing encephalopathy of childhood. Pediatr Neurol. 2019;98:80–4.31201070 10.1016/j.pediatrneurol.2019.04.009
62. Geng C Zhao W Wang Z Wu J Jiang D Jiang N Liu M Yao M Guan H Acute necrotizing encephalopathy associated with COVID-19: case series and systematic review J Neurol 2023 270 5171 5181 10.1007/s00415-023-11915-8 37695531
Geng C, Zhao W, Wang Z, Wu J, Jiang D, Jiang N, Liu M, Yao M, Guan H. Acute necrotizing encephalopathy associated with COVID-19: case series and systematic review. J Neurol. 2023;270:5171–81.37695531 10.1007/s00415-023-11915-8
